CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-21 | Redmile Group, LLC 10% owner | Conversion | +671,808 | 671,808 | ||
| 2019-06-21 | Redmile Group, LLC 10% owner | Conversion · Series B Convertible Preferred Stock | −671,808 | 0 |
Page 1 of 1 · 2 trades